Maternal And Neonatal Vaccination - How Early Can We Protect Infants?
Funder
National Health and Medical Research Council
Funding Amount
$196,331.00
Summary
Currently, only hepatitis B vaccine is routinely given at birth and for all other vaccines the earliest recommended administration is at 6 weeks old. This is too late to protect infants against pertussis and the most severe cases (hospitalisation or death) occur before 4 months. This research aims to assess if birth pertussis vaccination can protect infants earlier, measure the longevity of immunity following birth hepatitis B vaccination and examine the potential role for maternal vaccination
ASPREE is the largest clinical trial ever conducted in Australia and will determine whether daily low dose aspirin prevents disease in healthy older people. The study was well-funded initially but will require additional support to complete the vital final stage of data collection and analysis. This will enable the study to answer important questions about the benefits and risks of aspirin in this age group and its effect on disability free survival.
‘Breaking The Cycle’ Of Crime - Improved Health And Justice Outcomes For Offenders Through Effective Interventions
Funder
National Health and Medical Research Council
Funding Amount
$838,845.00
Summary
Offender population ensure some of the worst health outcomes in the community and impose a significant burden on society. Addressing their health and criminogenic needs through effective interventions not only improves individual outcomes but has profound financial and societal benefits. This fellowship will focus on developing effective interventions in the areas of infectious diseases, mental health and violence, including domestic and family violence.
Kidney Function And The Effectiveness And Safety Of Direct Oral Anticoagulants In Atrial Fibrillation: The KODIAK-AF Study
Funder
National Health and Medical Research Council
Funding Amount
$451,730.00
Summary
The direct oral anticoagulants (DOACs) are a relatively new type of drug that are used to prevent the onset of stroke among patients with atrial fibrillation (AF). While these drugs have been demonstrated to be safe and effective among AF patients, in those AF patients with chronic kidney disease (CKD), there is uncertainty as to whether these drugs are similarly safe. This program of research will study the safety profile of DOACs in patients with AF and CKD.
Centre Of Research Excellence On Sitting Time And Chronic Disease Prevention – Mechanisms, Measurement And Interventions
Funder
National Health and Medical Research Council
Funding Amount
$2,657,874.00
Summary
Australian research has identified serious health consequences arising from the 7 to 10 hours of daily sitting that most people do, especially in relation to ‘diseases of inactivity’ – type 2 diabetes, coronary heart disease and breast and colon cancer – that are an unwelcome burden on individuals, families and health systems. This new research examines the practical feasibility and the preventive-health benefits of changing children’s and adults’ sitting time in schools, workplaces and the home ....Australian research has identified serious health consequences arising from the 7 to 10 hours of daily sitting that most people do, especially in relation to ‘diseases of inactivity’ – type 2 diabetes, coronary heart disease and breast and colon cancer – that are an unwelcome burden on individuals, families and health systems. This new research examines the practical feasibility and the preventive-health benefits of changing children’s and adults’ sitting time in schools, workplaces and the home environment.Read moreRead less
Unlocking The Health Effects Of Sitting To Reduce Chronic Disease
Funder
National Health and Medical Research Council
Funding Amount
$638,517.00
Summary
This fellowship involves a series of studies that will fill gaps in evidence to inform national and international public health and clinical guideline recommendations on sitting time. It will provide crucial evidence on dose-response relationships, underlying mechanisms and the feasibility of making the relevant behavioural changes, providing more-precise evidence-based contributions to the development of public health policy and guidelines on sitting time.
The Natural History Of Unassisted Smoking Cessation In Australia
Funder
National Health and Medical Research Council
Funding Amount
$329,595.00
Summary
The majority of ex-smokers who successfully quit have done so without using pharmaceutical or counselling support. This study will produce pioneering insights into how and why so many smokers successfully quit without formal assistance. The findings will be conveyed to government, not-for-profit groups, and tobacco cessation professionals in order to help foster favourable social climates for smoking cessation and construct empowering messages about smoking cessation via self-change strategies.
Ageing Well And Productively: Pathways To Healthy Workforce Participation And Caregiving.
Funder
National Health and Medical Research Council
Funding Amount
$143,660.00
Summary
Good health is vital to increase workforce participation,which enables us to pay for rising health care costs. This study will examine how socio-economic, behavioural, environmental and health-related factors impact on healthy workforce participation among older Australians. It will identify ways to prevent people having to retire early because of ill-health and will inform policy makers and health program developers about how best to maintain or increase a healthy workforce participation.